Effects of Fremanezumab on Medication Overuse in Japanese Chronic Migraine Patients: Post Hoc Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

被引：0
|
作者：
Noboru Imai
Yuki Isogai
Yoshiyuki Shibasaki
Masami Nakai
Miki Ishida
Xiaoping Ning
Nobuyuki Koga
机构：
[1] Japanese Red Cross Shizuoka Hospital,Medical Affairs
[2] Otsuka Pharmaceutical Co.,undefined
[3] Ltd,undefined
[4] Otsuka Pharmaceutical Co.,undefined
[5] Ltd,undefined
[6] Teva Branded Pharmaceutical Products R&D,undefined
[7] Inc,undefined
[8] Otsuka Pharmaceutical Co.,undefined
[9] Ltd,undefined
来源：
Neurology and Therapy | 2023年 / 12卷
关键词：
Calcitonin gene-related peptide; Chronic migraine; Fremanezumab; Japanese; Medication overuse;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1981 / 1991
页数：10
相关论文
共 50 条
  • [1] Effects of Fremanezumab on Medication Overuse in Japanese Chronic Migraine Patients: Post Hoc Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Imai, Noboru
    Isogai, Yuki
    Shibasaki, Yoshiyuki
    Nakai, Masami
    Ishida, Miki
    Ning, Xiaoping
    Koga, Nobuyuki
    NEUROLOGY AND THERAPY, 2023, 12 (06) : 1981 - 1991
  • [2] Effects of fremanezumab on migraine-associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double-blind, placebo-controlled trial
    Tatsumoto, Muneto
    Ishida, Miki
    Iba, Katsuhiro
    Kim, Byung-Kun
    Ning, Xiaoping
    Osawa, Chihiro
    Nakai, Masami
    Kurita, Yuka
    HEADACHE, 2024,
  • [3] Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients
    Sakai, Fumihiko
    Suzuki, Norihiro
    Kim, Byung-Kun
    Igarashi, Hisaka
    Hirata, Koichi
    Takeshima, Takao
    Ning, Xiaoping
    Shima, Tomoko
    Ishida, Miki
    Iba, Katsuhiro
    Kondo, Hiroyuki
    Koga, Nobuyuki
    HEADACHE, 2021, 61 (07): : 1092 - 1101
  • [4] Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients
    Sakai, Fumihiko
    Suzuki, Norihiro
    Kim, Byung-Kun
    Tatsuoka, Yoshihisa
    Imai, Noboru
    Ning, Xiaoping
    Ishida, Miki
    Nagano, Kaori
    Iba, Katsuhiro
    Kondo, Hiroyuki
    Koga, Nobuyuki
    HEADACHE, 2021, 61 (07): : 1102 - 1111
  • [5] Botulinum toxin A and acute detoxification in chronic migraine and medication overuse: a randomised, double-blind, placebo-controlled trial
    Pijpers, Judith A.
    Kies, Dennis A.
    Louter, Mark A.
    van Zwet, Erik W.
    Ferrari, Michel D.
    Terwindt, Gisela M.
    CEPHALALGIA, 2017, 37 : 103 - 103
  • [6] Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study
    Shengyuan Yu
    Jiying Zhou
    Guogang Luo
    Zheman Xiao
    Anders Ettrup
    Gary Jansson
    Ioana Florea
    Kristina Ranc
    Patricia Pozo-Rosich
    BMC Neurology, 23
  • [7] Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study
    Yu, Shengyuan
    Zhou, Jiying
    Luo, Guogang
    Xiao, Zheman
    Ettrup, Anders
    Jansson, Gary
    Florea, Ioana
    Ranc, Kristina
    Pozo-Rosich, Patricia
    BMC NEUROLOGY, 2023, 23 (01)
  • [8] Arterial effects of acupuncture in migraine: A randomized, double-blind, placebo-controlled trial
    Boutouyrie, P
    Laloux, B
    Corvisier, R
    Vulser, C
    Girard, A
    Laurent, S
    HYPERTENSION, 2005, 46 (04) : 897 - 897
  • [9] Efficacy and Safety of Toutongning Capsule in Patients with Migraine: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Yu, Shengyuan
    Ran, Ye
    Wan, Qi
    Yang, Xiaosu
    Chen, Huisheng
    Wang, Hebo
    Hu, Xueqiang
    Mao, Shanping
    Yu, Tingming
    Luo, Guogang
    Guan, Yangtai
    Gao, Xuguang
    Li, Xin
    Zhou, Muke
    Li, Yu
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2019, 25 (12) : 1215 - 1224
  • [10] The effects of qishen granules for patients with chronic heart failure: A multicenter randomized double-blind placebo-controlled trial
    Du, Kangjia
    Liu, Junjie
    Tan, Nannan
    Huang, Xinyi
    Wang, Juan
    Zhao, Huihui
    Wang, Wei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
12345